VP, Clinical Pharmacology
Frontier Medicines
Summary
Frontier is seeking a VP, Clinical Pharmacology to lead clinical pharmacology strategy across our oncology clinical portfolio. This is a senior, cross-functional leadership role spanning nonclinical pharmacology (PK/PD/ADME and bioanalysis), clinical pharmacology (bioanalysis, dose selection, and PK/PD strategy) for active trials, DMPK oversight, and clinical pharmacology/biopharmaceutics input into CMC decisions.
Job description
This individual will serve as Frontier's senior-most clinical pharmacology leader, setting strategy and building out the function and will partner closely with Clinical Development, Regulatory Affairs, Biometrics, and CMC, bringing hands-on scientific expertise to trial design, dose optimization, and regulatory strategy for our oncology programs.
What will you be doing?
- Lead clinical pharmacology strategy across active clinical trials, including dose selection, dose escalation, dose optimization, and exposure-response analyses.
- Oversee nonclinical and clinical bioanalytical strategies and execution.
- Oversee DMPK activities in support of clinical and nonclinical program needs.
- Provide clinical pharmacology and biopharmaceutics input into CMC decisions, including formulation strategy, bioavailability, and drug-drug interaction risk.
- Lead the development of clinical pharmacology content for regulatory submissions, including IND/CTA sections and briefing documents, in partnership with Regulatory Affairs.
- Serve as the clinical pharmacology representative in interactions with FDA and other health authorities, including Type B/C meetings, briefing document preparation, and responses to information requests.
- Apply model-informed drug development (MIDD) approaches, including PBPK modeling and biomarker strategy, to inform dose and development decisions.
- Partner closely with Clinical Development, Biometrics, Regulatory Affairs, and CMC to ensure clinical pharmacology and DMPK considerations are built into trial design and regulatory decisions from the outset.
- Serve as the primary hands-on contributor for clinical pharmacology and DMPK activities in the near term, working closely with CROs and consultants to execute analyses and deliverables, and ultimately hire and lead a small internal clinical pharmacology team as the portfolio grows.
- Manage CRO relationships supporting clinical pharmacology and DMPK activities.
What are we looking for?
- PhD, PharmD, or equivalent advanced degree in pharmacology, translational sciences, or a related field.
- 15+ years of clinical pharmacology experience in biotech or pharma, including leading clinical pharmacology strategy across clinical trials with oversight of DMPK.
- Oncology therapeutic area experience required.
- Strong cross-functional collaboration skills, particularly with Clinical Development, Biometrics, Regulatory Affairs, and CMC.
- Demonstrated experience managing CRO and consultant relationships as the primary means of executing clinical pharmacology and DMPK work. This role will operate this way initially, before building an internal team.
- Comfortable operating in a fast-paced, dynamic environment with a proactive, roll-up-your-sleeves mindset.
- Legally authorized to work in the United States.
Requirements
- PhD, PharmD, or equivalent advanced degree in pharmacology, translational sciences, or a related field
- 15+ years of clinical pharmacology experience in biotech or pharma
- Experience leading clinical pharmacology strategy across clinical trials with oversight of DMPK
- Oncology therapeutic area experience required
- Strong cross-functional collaboration skills with Clinical Development, Biometrics, Regulatory Affairs, and CMC
- Demonstrated experience managing CRO and consultant relationships
- Comfortable operating in a fast-paced, dynamic environment with a proactive, roll-up-your-sleeves mindset
- Legally authorized to work in the United States
Benefits
- Medical, Dental & Vision
- 401(k) & IRA
- Life Insurance
- Paid Time Off
- Maternity & Paternity Leave
- Short & Long Term Disability
- Training & Development
- Free Food & Snacks
- Wellness Resources
- Stock Option Plan
Company overview
Frontier Medicines is a clinical-stage precision medicine biotechnology company founded in 2018 that specializes in developing breakthrough therapies against previously undruggable disease-causing proteins. The company has pioneered a proprietary discovery and development platform called the Frontier™ Platform, which integrates chemoproteomics, covalent drug discovery, and machine learning technologies to target proteins considered inaccessible to conventional drug discovery approaches. Frontier Medicines focuses on oncology and immunology, with its lead program FMC-376 being a first-in-class dual inhibitor of both active and inactive KRAS G12C mutations, which are prevalent in non-small cell lung, colorectal, and pancreatic cancers. The company maintains offices in South San Francisco, California and Boston, Massachusetts, and has established a strategic global partnership with AbbVie to develop novel therapies against difficult-to-drug targets in oncology and immunology. Frontier Medicines is advancing a diversified pipeline of wholly-owned precision medicines and has raised significant venture capital funding to support its mission of expanding the therapeutic landscape for genetically-defined patient populations.